Robert M Naclerio
Overview
Explore the profile of Robert M Naclerio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
1494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Clark J, Naclerio R
J Allergy Clin Immunol Pract
. 2025 Mar;
13(3):687-688.
PMID: 40049788
No abstract available.
2.
Clark J, Meltzer E, Naclerio R
World Allergy Organ J
. 2025 Feb;
18(2):101027.
PMID: 39925982
Diphenhydramine, once a pioneering antihistamine, is now overshadowed by second-generation antihistamines with similar efficacy and fewer adverse effects. Current data suggest that the adverse side-effect profile of diphenhydramine is higher...
3.
Naclerio R, Ansotegui I, Canonica G, Rouadi P, Zhang L, Murrieta-Aguttes M
World Allergy Organ J
. 2024 Sep;
17(9):100950.
PMID: 39252789
Allergic rhinitis (AR) and urticaria affect a sizable portion of the population worldwide, resulting in reduced quality-of-life and productivity and increased healthcare costs. Fexofenadine (FEX) is a non-sedating second-generation H...
4.
Ansotegui I, Bousquet J, Canonica G, Demoly P, Gomez R, Meltzer E, et al.
Curr Med Res Opin
. 2024 Jul;
40(8):1297-1309.
PMID: 39028636
Objective: Fexofenadine is a second-generation inverse agonist of H-receptor of histamine which is highly selective with proven efficacy in relieving symptoms associated with allergic conditions. It has an additional benefit...
5.
Naclerio R, Bousquet J
J Allergy Clin Immunol Pract
. 2024 Apr;
12(6):1493-1494.
PMID: 38641128
No abstract available.
6.
Naclerio R, Hamilos D
J Allergy Clin Immunol Pract
. 2024 Apr;
12(4):1062-1064.
PMID: 38583923
No abstract available.
7.
Ow R, Shotts S, Kakarlapudi V, McIntyre J, Naclerio R, You C, et al.
Am J Rhinol Allergy
. 2022 Jun;
36(6):733-740.
PMID: 35708181
Background: The efficacy of topical corticosteroids is limited in chronic rhinosinusitis (CRS) due to rapid clearance from the nasal cavity and insufficient drug delivery to inflamed sinonasal passages. LYR-210 is...
8.
Clark J, Pinto J, Naclerio R
Int Forum Allergy Rhinol
. 2022 Jan;
12(5):685-689.
PMID: 35061938
Is it time for medical insurance companies to organize and fund clinical research that evaluates the role of new treatments (drugs or device-based therapies) in the context of existing clinical...
9.
Clark J, Pang S, Naclerio R, Kashima M
J Investig Med
. 2021 Aug;
69(8):1399-1403.
PMID: 34348963
Transnasal swab testing for the detection of SARS-CoV-2 is well established. The Centers for Disease Control and Prevention advocates swabbing either of the anterior nares, middle turbinate, or nasopharynx for...
10.
Clark J, Naclerio R, Kim J, Kashima M
J Allergy Clin Immunol Pract
. 2021 Apr;
9(7):2894-2895.
PMID: 33863680
No abstract available.